ARCT

Arcturus Therapeutics Holdings Inc.

Company with tickers: ARCT

Market Cap

$199.95M

Shares Outstanding

28,423,069

CIK

1768224

CUSIP

03969T109

13F Activity (30d)

2 filings 1 filers

Website

Visit website

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Past events

Date	Event	Type
2026-05-26	Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference READ MORE	Conference
2026-05-07	Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress READ MORE	Event
2026-04-27	Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 READ MORE	Event
2026-03-05	Arcturus Therapeutics to Attend Upcoming Investor Conference READ MORE	Conference
2026-03-03	Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress READ MORE	Event
2026-02-17	Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 READ MORE	Event
2026-01-08	Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference READ MORE	Conference
2025-11-24	Arcturus Therapeutics to Attend Upcoming Investor Conference READ MORE	Conference
2025-11-10	Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress READ MORE	Event
2025-11-04	Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE	Conference
2025-10-28	Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 READ MORE	Event
2025-10-22	Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program READ MORE	Event
2025-08-26	Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE	Conference
2025-08-11	Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress READ MORE	Event
2025-07-24	Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025 READ MORE	Event
2025-07-23	Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE	Conference
2025-06-30	Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program READ MORE	Event
2025-06-23	Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency READ MORE	Presentation
2025-05-29	Arcturus Therapeutics to Attend Upcoming Investor Conferences READ MORE	Conference
2025-05-12	Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress READ MORE	Event